NCT01492608 (MASP) is a Phase 3 clinical trial of Magnesium sulphate in Cerebral Palsy, sponsored by Hvidovre University Hospital.

Who is sponsoring NCT01492608?

NCT01492608 is sponsored by Hvidovre University Hospital.

What drugs are being tested in NCT01492608?

Interventions in NCT01492608: Magnesium sulphate.

What condition does NCT01492608 study?

NCT01492608 studies Cerebral Palsy.

Is NCT01492608 still recruiting?

NCT01492608 is currently completed. Last updated 14 August 2019.

Last reviewed 2019-08-14 · How we verify

NCT01492608: MASP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Magnesium Sulphate for Preterm Birth (MASP Study)

Completed Phase 3 Last updated 14 August 2019

What this trial tests

Phase 3 trial testing Magnesium sulphate in Cerebral Palsy in 560 participants. Completed in 12 August 2019.

Timeline

16 December 2011

Primary endpoint
12 August 2019

12 August 2019

Quick facts

Lead sponsor	Hvidovre University Hospital
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	560
Start date	16 December 2011
Primary completion	12 August 2019
Estimated completion	12 August 2019
Sites	14 locations across Denmark

Drugs / interventions tested

Magnesium sulphate

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →

Sponsor

Hvidovre University Hospital

Who can join

Adults 18 to 50, female only, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to assess whether magnesium sulphate for women at risk of preterm birth can protect their children against cerebral palsy. The results from this randomised controlled trial will be added to the previous meta-analysis to obtain firm evidence for magnesium sulphate as a neuroprotector, and determine whether it should be used as standard therapy for women in preterm birth.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Shepherd ES, Goldsmith S, Doyle LW, Middleton P, et al · · 2024 · cited 18× · PMID 38726883 · DOI 10.1002/14651858.cd004661.pub4
Does Antenatal Administration of Magnesium Sulphate Prevent Cerebral Palsy and Mortality in Preterm Infants? A Study Protocol.
Wolf HT, Hegaard HK, Pinborg AB, Huusom LD. · · 2015 · cited 4× · PMID 29546132 · DOI 10.3934/publichealth.2015.4.727

Verify or expand the search:

Other trials of Magnesium sulphate

Trials testing the same drug.

NCT06675500 — Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery · Phase 3 · completed
NCT06612996 — Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering · Phase 4 · not yet recruiting
NCT06595017 — Lidocaine Versus Magnesium Sulphate in Management of Myofascial Pain Dysfunction Syndrome · Phase 2 · not yet recruiting
NCT06977425 — Efficacy of Intraoperative Magnesium Sulphate vs Dexmedetomidine on Emergence Agitation in Pediatric Patients · NA · completed
NCT07139522 — Dexamethasone Versus Magnesium Sulphate as an Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block fo · NA · recruiting

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Other Hvidovre University Hospital trials

Trials by the same sponsor.

NCT07561164 — Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery · NA · not yet recruiting
NCT06909240 — Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DV · NA · recruiting
NCT07054216 — Probiotic for Infants · NA · recruiting
NCT07029334 — Effectiveness Evaluation of Social Prescribing · recruiting
NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01492608 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hvidovre University Hospital
Last refreshed: 14 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01492608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing